Triple Negative Breast Cancer

Molecular Markers of Epithelial-to-Mesenchymal Transition Are Associated with Tumor Aggressiveness in Breast Carcinoma

(2014) Seema Sethi et al.   Translational Oncology

Characteristics of Invasive Breast Ductal Carcinoma, NOS, Diagnosed in a Tertiary Institution in the East Coast of Malaysia with a Focus on Tumor Angiogenesis

(2013) Ewe Seng Ch'ng et al.   Asian Pacific Journal of Cancer Prevention

Clinicopathological and Prognostic Characteristics of Triple-Negative Breast Cancer (TNBC) in Chinese Patients: A Retrospective Study

(2013) Chun-Yan Li et al.   Asian Pacific Journal of Cancer Prevention

Association of Immunohistochemically Defined Molecular Subtypes with Clinical Response to Presurgical Chemotherapy in Patients with Advanced Breast Cancer

(2013) Samina Khokher et al.   Asian Pacific Journal of Cancer Prevention

HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India

(2013) Syeda Zubeda et al.   Asian Pacific Journal of Cancer Prevention

Vitamin D and MicroRNAs in Bone

(2013) Thomas S. Lisse et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Clinical Significance of Basal-like Breast Cancer in Chinese Women in Heilongjiang Province

(2012) Ying Liu et al.   Asian Pacific Journal of Cancer Prevention

Inhibiting Angiogenesis in Breast Cancer: The Beginning of the End or the End of the Beginning?

(2012) Hope S. Rugo   JOURNAL OF CLINICAL ONCOLOGY

The hazards of randomized phase II trials

(2011) P. N. Lara et al.   ANNALS OF ONCOLOGY

Histological, molecular and functional subtypes of breast cancers

(2011) Gautam K. Malhotra et al.   CANCER BIOLOGY & THERAPY

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

(2011) Lauren L.C. Marotta et al.   JOURNAL OF CLINICAL INVESTIGATION

Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells

(2011) Yong-Wei Zhang et al.   NUCLEIC ACIDS RESEARCH

Triple-Negative Breast Cancer

(2010) Anthony D. Elias   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer

(2010) Monika L. Burness et al.   CANCER JOURNAL

Triple-negative breast cancer: Present challenges and new perspectives

(2010) Franca Podo et al.   Molecular Oncology

Molecular Stratification of Triple-Negative Breast Cancers

(2010) C. M. Perou   ONCOLOGIST

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

(2009) B. K. Linderholm et al.   ANNALS OF ONCOLOGY

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

(2009) B. Corkery et al.   ANNALS OF ONCOLOGY

The epidemiology of triple-negative breast cancer, including race

(2009) Katrina F. Trivers et al.   CANCER CAUSES & CONTROL

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

(2008) T. Byrski et al.   BREAST CANCER RESEARCH AND TREATMENT

Beyond Cytotoxic Chemotherapy for the First-Line Treatment of HER2-Negative, Hormone-Insensitive Metastatic Breast Cancer: Current Status and Future Opportunities

(2008) Alison K. Conlin et al.   Clinical Breast Cancer

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair

(2008) Alan Ashworth   JOURNAL OF CLINICAL ONCOLOGY

The genomic profile ofHER2-amplified breast cancers: the influence of ER status

(2008) C Marchiò et al.   JOURNAL OF PATHOLOGY